LILLY DIABETES MANAGEMENT AGREEMENTS WITH MEDCO, DPS WILL CONTINUE AFTER PCS ACQUISITION; PBMs ARE NOT LEADING DRUG COMPANIES INTO DISTRIBUTION SECTOR
Executive Summary
Lilly intends to continue participation in diabetes management programs with Merck/Medco and SmithKline Beecham/DPS after the acquisition of PCS, the company said July 13.